Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Class A common stock, par value $0.00001 per share
-
Shares outstanding
-
114M
-
Number of holders
-
268
-
Total 13F shares, excl. options
-
114M
-
Shares change
-
+8.94M
-
Total reported value, excl. options
-
$993M
-
Value change
-
+$50.9M
-
Put/Call ratio
-
0.69
-
Number of buys
-
150
-
Number of sells
-
-118
-
Price
-
$8.73
Significant Holders of 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) as of Q1 2025
323 filings reported holding TXG - 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share as of Q1 2025.
10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) has 268 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 114M shares
of 114M outstanding shares and own 99.48% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (12.8M shares), VANGUARD GROUP INC (11.1M shares), FMR LLC (9.89M shares), UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC (7.1M shares), BlackRock, Inc. (6.67M shares), MILLENNIUM MANAGEMENT LLC (5.38M shares), Sumitomo Mitsui Trust Group, Inc. (5.36M shares), Nikko Asset Management Americas, Inc. (5.36M shares), MORGAN STANLEY (2.77M shares), and BANK OF AMERICA CORP /DE/ (2.67M shares).
This table shows the top 268 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.